Cohance Lifesciences Limited (COHANCE) announced an additional USD 13 million investment in NJ Bio and USD 5 million in Aruka Bio to strengthen its Antibody-.
Max Healthcare Institute Limited unveils new 400 beds tower at Max Smart Super Speciality Hospital, Saket, expanding its capacity to 1,200 beds.
Suven Life Sciences Limited (SUVEN) completes patient enrollment in global Phase-3 study of Masupirdine for agitation associated with Alzheimer’s Dementia.
Sun Pharmaceutical Industries Limited commits to U.S. medicines pricing and access agreements, extending MFN pricing to state Medicaid programs.
Cipla Limited (NSE: CIPLA) partners with S BP Group for exclusive licensing of best-in-class HER2 bispecific ADC, aiming to enhance breast cancer treatment i.
Zydus Lifesciences Limited (ZYDUSLIFE) announces positive topline results from completed EVIDENCES-X Phase II(b) clinical trial for Saroglitazar Mg in MASH.
Aurobindo Pharma Limited (AUROPHARMA) announces the launch of generic Advair Diskus® in the US market by its subsidiary Lannett Company LLC.
Fischer Medical Ventures Limited (FISCHER) unveils the CLARION 64/128-Slice AI-Driven CT System, enhancing India’s medical imaging technology.
Metropolis Healthcare Limited (METROPOLIS) announces strategic plans from Investor & Analyst Meet 2026 to strengthen core, expand adjacencies, and compound s.
Sai Parenterals Limited renews AUD 30 million OTC supply agreement with Australian pharmacy chain, expanding product portfolio and agreement tenure.